Willingham MC - Search Results

1

Dual functions of the steroid hormone receptor coactivator 3 in modulating resistance to thyroid hormone.

Ying H, Furuya F, Willingham MC, Xu J, O'Malley BW, Cheng SY. Ying H, et al. Among authors: willingham mc. Mol Cell Biol. 2005 Sep;25(17):7687-95. doi: 10.1128/MCB.25.17.7687-7695.2005. Mol Cell Biol. 2005. PMID: 16107715 Free PMC article.

2

Expression of a dominant allele of human ARF1 inhibits membrane traffic in vivo.

Zhang CJ, Rosenwald AG, Willingham MC, Skuntz S, Clark J, Kahn RA. Zhang CJ, et al. Among authors: willingham mc. J Cell Biol. 1994 Feb;124(3):289-300. doi: 10.1083/jcb.124.3.289. J Cell Biol. 1994. PMID: 8294513 Free PMC article.

3

Testosterone regulates thyroid cancer progression by modifying tumor suppressor genes and tumor immunity.

Zhang LJ, Xiong Y, Nilubol N, He M, Bommareddi S, Zhu X, Jia L, Xiao Z, Park JW, Xu X, Patel D, Willingham MC, Cheng SY, Kebebew E. Zhang LJ, et al. Among authors: willingham mc. Carcinogenesis. 2015 Apr;36(4):420-8. doi: 10.1093/carcin/bgv001. Epub 2015 Jan 9. Carcinogenesis. 2015. PMID: 25576159 Free PMC article.

4

Inhibition of STAT3 signaling blocks obesity-induced mammary hyperplasia in a mouse model.

Park JW, Zhao L, Willingham MC, Cheng SY. Park JW, et al. Among authors: willingham mc. Am J Cancer Res. 2017 Mar 1;7(3):727-739. eCollection 2017. Am J Cancer Res. 2017. PMID: 28401024 Free PMC article.

5

Targeting MYC as a Therapeutic Intervention for Anaplastic Thyroid Cancer.

Enomoto K, Zhu X, Park S, Zhao L, Zhu YJ, Willingham MC, Qi J, Copland JA, Meltzer P, Cheng SY. Enomoto K, et al. Among authors: willingham mc. J Clin Endocrinol Metab. 2017 Jul 1;102(7):2268-2280. doi: 10.1210/jc.2016-3771. J Clin Endocrinol Metab. 2017. PMID: 28368473 Free PMC article.

6

SAHA-induced loss of tumor suppressor Pten gene promotes thyroid carcinogenesis in a mouse model.

Zhu X, Kim DW, Zhao L, Willingham MC, Cheng SY. Zhu X, et al. Among authors: willingham mc. Endocr Relat Cancer. 2016 Jul;23(7):521-33. doi: 10.1530/ERC-16-0103. Epub 2016 Jun 7. Endocr Relat Cancer. 2016. PMID: 27267120 Free PMC article.

7

Loss of tyrosine phosphorylation at Y406 abrogates the tumor suppressor functions of the thyroid hormone receptor β.

Park JW, Zhao L, Willingham MC, Cheng SY. Park JW, et al. Among authors: willingham mc. Mol Carcinog. 2017 Feb;56(2):489-498. doi: 10.1002/mc.22511. Epub 2016 Jun 14. Mol Carcinog. 2017. PMID: 27254276 Free PMC article.

8

Inhibition of STAT3 activity delays obesity-induced thyroid carcinogenesis in a mouse model.

Park JW, Han CR, Zhao L, Willingham MC, Cheng SY. Park JW, et al. Among authors: willingham mc. Endocr Relat Cancer. 2016 Jan;23(1):53-63. doi: 10.1530/ERC-15-0417. Epub 2015 Nov 9. Endocr Relat Cancer. 2016. PMID: 26552408 Free PMC article.

9

Synergistic signaling of KRAS and thyroid hormone receptor β mutants promotes undifferentiated thyroid cancer through MYC up-regulation.

Zhu X, Zhao L, Park JW, Willingham MC, Cheng SY. Zhu X, et al. Among authors: willingham mc. Neoplasia. 2014 Sep;16(9):757-69. doi: 10.1016/j.neo.2014.08.003. Neoplasia. 2014. PMID: 25246276 Free PMC article.

10

A histone deacetylase inhibitor improves hypothyroidism caused by a TRα1 mutant.

Kim DW, Park JW, Willingham MC, Cheng SY. Kim DW, et al. Among authors: willingham mc. Hum Mol Genet. 2014 May 15;23(10):2651-64. doi: 10.1093/hmg/ddt660. Epub 2013 Dec 30. Hum Mol Genet. 2014. PMID: 24381310 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results